Zelda intends on sourcing the cannabinoid research material via a supply agreement with AusCann Group Holdings Ltd. AusCann has a partnership with the world’s largest medical cannabis cultivator and processor - Canadian group Canopy Growth Corporation. Subject to AusCann securing the appropriate import permits, and Canopy securing an export permit, this material will be sourced from Canada and supplied to the Telethon Kids Institute for the approved research purposes. These research activities fall within the recently passed Australian Narcotics Drug Amendment Act and re-scheduling of cannabis from Schedule 9 (prohibited substance) to Schedule 8 (controlled drug) under the Poisons Standard.
TWH Price at posting:
1.2¢ Sentiment: Buy Disclosure: Held